Terms: = Colorectal cancer AND FES, FPS, 2242, ENSG00000182511, P07332 AND Treatment
19 results:
1. Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study).
Kinos S; Hagman H; Halonen P; Soveri LM; O'Reilly M; Pfeiffer P; Frödin JE; Sorbye H; Heervä E; Liposits G; Kallio R; Ålgars A; Ristamäki R; Salminen T; Bärlund M; Shah CH; McDermott R; Röckert R; Flygare P; Kwakman J; Teske A; Punt C; Glimelius B; Österlund P
Acta Oncol; 2024 May; 63():248-258. PubMed ID: 38698698
[TBL] [Abstract] [Full Text] [Related]
2. Characterizing and forecasting neoantigens-resulting from MUC mutations in COAD.
Chen M; Zhang X; Ming Z; Lingyu ; Feng X; Han Z; An HX
J Transl Med; 2024 Mar; 22(1):315. PubMed ID: 38539235
[TBL] [Abstract] [Full Text] [Related]
3. Relationship between Chemotherapy-Induced Diarrhea and Intestinal Microbiome Composition.
Kawasaki Y; Kakimoto K; Tanaka Y; Shimizu H; Nishida K; Numa K; Kinoshita N; Tatsumi Y; Nakazawa K; Koshiba R; Hirata Y; Ota K; Sakiyama N; Terazawa T; Takeuchi T; Miyazaki T; Goto M; Yokota H; Makizaki Y; Tanaka Y; Nakajima S; Ohno H; Higuchi K; Nakamura S; Nishikawa H
Digestion; 2023; 104(5):357-369. PubMed ID: 37231829
[TBL] [Abstract] [Full Text] [Related]
4. Fluoropyrimidine-induced hand-foot syndrome and cardiotoxicity: recommendations for the use of the oral fluoropyrimidine S-1 in metastatic colorectal cancer.
Punt CJA; Heinemann V; Maughan T; Cremolini C; Van Cutsem E; McDermott R; Bodoky G; André T; Osterlund P; Teske AJ; Pfeiffer P
ESMO Open; 2023 Apr; 8(2):101199. PubMed ID: 37018874
[TBL] [Abstract] [Full Text] [Related]
5. Precision fluoropyrimidines dosing in a compound heterozygous variant carrier of the DPYD gene: a case report.
Baiardi G; Clavarezza M; Stella M; Casazza S; De Censi A; Mattioli F
Cancer Chemother Pharmacol; 2023 May; 91(5):435-439. PubMed ID: 36890284
[TBL] [Abstract] [Full Text] [Related]
6. Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis.
Lin JF; Hu PS; Wang YY; Tan YT; Yu K; Liao K; Wu QN; Li T; Meng Q; Lin JZ; Liu ZX; Pu HY; Ju HQ; Xu RH; Qiu MZ
Signal Transduct Target Ther; 2022 Feb; 7(1):54. PubMed ID: 35221331
[TBL] [Abstract] [Full Text] [Related]
7. Fermentation profile, cholesterol-reducing properties and chemopreventive potential of β-glucans from
Schlörmann W; Bockwoldt JA; Mayr MF; Lorkowski S; Dawczynski C; Rohn S; Ehrmann MA; Glei M
Food Funct; 2021 Nov; 12(21):10615-10631. PubMed ID: 34585204
[TBL] [Abstract] [Full Text] [Related]
8. How I treat stage II colon cancer patients.
Taieb J; Karoui M; Basile D
ESMO Open; 2021 Aug; 6(4):100184. PubMed ID: 34237612
[TBL] [Abstract] [Full Text] [Related]
9. Persistent High Rate of Positive Margins and Postoperative Complications After Surgery for cT4 Rectal cancer at a National Level.
de Nes LCF; Drager LD; Verstegen MG; Burger JWA; Tanis PJ; de Wilt JHW;
Dis Colon Rectum; 2021 Apr; 64(4):389-398. PubMed ID: 33651005
[TBL] [Abstract] [Full Text] [Related]
10. Chemistry of Fluorinated Pyrimidines in the Era of Personalized Medicine.
Gmeiner WH
Molecules; 2020 Jul; 25(15):. PubMed ID: 32751071
[TBL] [Abstract] [Full Text] [Related]
11. Efficacy and Cardiotoxic Safety Profile of Raltitrexed in Fluoropyrimidines-Pretreated or High-Risk Cardiac Patients With GI Malignancies: Large Single-Center Experience.
Khan K; Rane JK; Cunningham D; Rao S; Watkins D; Starling N; Kalaitzaki E; Forster M; Braconi C; Valeri N; Gerlinger M; Chau I
Clin Colorectal Cancer; 2019 Mar; 18(1):64-71.e1. PubMed ID: 30404764
[TBL] [Abstract] [Full Text] [Related]
12. A kinome siRNA screen identifies HGS as a potential target for liver cancers with oncogenic mutations in CTNNB1.
Canal F; Anthony E; Lescure A; Del Nery E; Camonis J; Perez F; Ragazzon B; Perret C
BMC Cancer; 2015 Dec; 15():1020. PubMed ID: 26715116
[TBL] [Abstract] [Full Text] [Related]
13. Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone.
Talbot JN; Gligorov J; Nataf V; Montravers F; Huchet V; Michaud L; Ohnona J; Balogova S; Cussenot O; Daraï E; Lotz JP; Kerrou K
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):4-17. PubMed ID: 25693420
[TBL] [Abstract] [Full Text] [Related]
14. Influence of dihydropyrimidine dehydrogenase gene (DPYD) coding sequence variants on the development of fluoropyrimidine-related toxicity in patients with high-grade toxicity and patients with excellent tolerance of fluoropyrimidine-based chemotherapy.
Kleibl Z; Fidlerova J; Kleiblova P; Kormunda S; Bilek M; Bouskova K; Sevcik J; Novotny J
Neoplasma; 2009; 56(4):303-16. PubMed ID: 19473056
[TBL] [Abstract] [Full Text] [Related]
15. Promoter methylation blocks fes protein-tyrosine kinase gene expression in colorectal cancer.
Shaffer JM; Smithgall TE
Genes Chromosomes Cancer; 2009 Mar; 48(3):272-84. PubMed ID: 19051325
[TBL] [Abstract] [Full Text] [Related]
16. The effects of quercetin on SW480 human colon carcinoma cells: a proteomic study.
Mouat MF; Kolli K; Orlando R; Hargrove JL; Grider A
Nutr J; 2005 Mar; 4():11. PubMed ID: 15748282
[TBL] [Abstract] [Full Text] [Related]
17. Family physicians' perspectives on practice guidelines related to cancer control.
Zitzelsberger L; Grunfeld E; Graham ID
BMC Fam Pract; 2004 Nov; 5():25. PubMed ID: 15544701
[TBL] [Abstract] [Full Text] [Related]
18. Efficacy and safety of FdUMP[10] in treatment of HT-29 human colon cancer xenografts.
Liu C; Willingham M; Liu J; Gmeiner WH
Int J Oncol; 2002 Aug; 21(2):303-8. PubMed ID: 12118325
[TBL] [Abstract] [Full Text] [Related]
19. [Phase II study of the water-soluble nitrosourea compound ACNU in advanced colorectal carcinomas].
Fiebig HH; Wellens W; Peukert M; Henss H; Arnold H; Westerhausen M; Löhr GW
Onkologie; 1984 Dec; 7(6):370-7. PubMed ID: 6396565
[TBL] [Abstract] [Full Text] [Related]
